Methods and compositions for modified ethanol inducible promoter systems

US9434953B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9434953-B2
Application numberUS-201113978133-A
CountryUS
Kind codeB2
Filing dateDec 15, 2011
Priority dateJan 18, 2011
Publication dateSep 6, 2016
Grant dateSep 6, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides nucleic acid molecules comprising one or more nucleotide sequences selected from the group consisting of the nucleotide sequence of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, and/or SEQ ID NO:10 that can be operably linked to a promoter, thereby making the promoter inducible by a chemical compound that can induce the expression of the alcohol dehydrogenase system of Aspergillus nidulans . Methods for making an inducible promoter and for making the expression of a nucleotide sequence of interest inducible are also provided. Further provided are plants, plant parts, and plant cells, comprising the compositions of the present invention.

First claim

Opening claim text (preview).

What is claimed is: 1. An isolated nucleic acid molecule comprising five to nine nucleotide sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 10, wherein the selected nucleotide sequences can be in any combination, in any orientation, and/or in any order, and wherein the five to nine nucleotide sequences are operably linked to a heterologous promoter. 2. The isolated nucleic acid molecule of claim 1 , wherein the heterologous promoter is further operably linked to a nucleotide sequence of interest. 3. A method of making a promoter inducible, comprising: a) constructing a nucleic acid molecule comprising five to nine nucleotide sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 10, in any combination, in any orientation, and/or in any order; and b) operably linking the nucleic acid molecule of (a) with the promoter, wherein the promoter is heterologous to the five to nine nucleotide sequences of the nucleic acid molecule. 4. The method of claim 3 , wherein the heterologous promoter is made inducible to a chemical compound selected from the group consisting of a primary alcohol, a primary monoamine, a ketone, a methyl ketone, a hydrolysable ester, an aliphatic aldehyde, and any combination thereof. 5. The method of claim 3 , wherein the heterologous promoter is made inducible to a chemical compound selected from the group consisting of ethanol, acetaldehyde, ethyl methyl ketone, acetone, ethylamine, cyclohexanone, butan-2-ol, 3-oxobutyric acid, propan-2-ol, propan-1-ol, butan-2-ol, threonine, and any combination thereof. 6. The method of claim 3 , wherein the heterologous promoter that is made inducible is a constitutive promoter, a tissue specific promoter, a developmentally regulated promoter, and/or a chemically inducible promoter that is inducible by compounds that do not induce the expression of the alcohol dehydrogenase system of Aspergillus nidulans. 7. The method of claim 3 , wherein the heterologous promoter is a minimal promoter. 8. The method of claim 3 , wherein the five to nine nucleotide sequences are at the 5 ′ end of the nucleic acid molecule. 9. A method of making the expression of a nucleotide sequence of interest inducible comprising operably linking the heterologous promoter of claim 1 to the nucleotide sequence of interest. 10. A promoter made by the method of claim 3 . 11. A plant, plant part or plant cell comprising the isolated nucleic acid molecule of claim 2 .

Assignees

Inventors

Classifications

  • Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

  • chemically inducible, e.g. tetracycline · CPC title

  • Phenotypically and genetically modified plants via recombinant DNA technology · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9434953B2 cover?
The present invention provides nucleic acid molecules comprising one or more nucleotide sequences selected from the group consisting of the nucleotide sequence of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, and/or SEQ ID NO:10 that can be operably linked to a promoter, thereby making the promoter inducible by a chemical compound that can induce the…
Who is the assignee on this patent?
Sainz Manuel Benito, Kinkema Mark David, Syngenta Participations Ag, and 1 more
What technology area does this patent fall under?
Primary CPC classification C12N15/8238. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).